Products/Services Used | Details | Operation |
---|---|---|
Neoantigen Peptide Service> | T cells were co-cultured with an equal number of patient-derived B cells immortalized with the EBV virus (EBV lymphoblastoid cell lines, EBV-LCL) and pulsed with different doses of mutated or wildtype neoantigen peptides (Genscript). | Get A Quote |
Personal neoantigen vaccines have been envisioned as an effective approach to induce, amplify and diversify antitumor T cell responses. To define the long-term effects of such a vaccine, we evaluated the clinical outcome and circulating immune responses of eight patients with surgically resected stage IIIB/C or IVM1a/b melanoma, at a median of almost 4 years after treatment with NeoVax, a long-peptide vaccine targeting up to 20 personal neoantigens per patient ( NCT01970358 ). All patients were alive and six were without evidence of active disease. We observed long-term persistence of neoantigen-specific T cell responses following vaccination, with ex vivo detection of neoantigen-specific T cells exhibiting a m... More